Table 3.
Number of Subjects | 1–5 Years (Tacro + MMF) |
>5 Years (Tacro + MMF) |
1–5 Years (Tacro) |
>5 Years (Tacro) |
|
---|---|---|---|---|---|
72 | 44 | 10 | 18 | ||
Therapeutic range | <120 µg/h/L | 23 (31.9%) | 20 (45.5%) | 6 (60.0%) | 8 (44.4%) |
120–150 µg/h/L |
23 (31.9%) | 11 (25.0%) | 4 (40.0%) | 5 (27.8%) | |
>150 µg/h/L | 26 (36.1%) | 13 (29.5%) | - | 5 (27.8%) |
MMF—mycophenolate mofetil; Tacro—tacrolimus.